Yes, one can say that ONT reads do still have higher error rates in comparison to Illumina short reads, but the situation has improved significantly in recent years. You can check the following resources:
https://nanoporetech.com/news/news-new-nanopore-sequencing-chemistry-developers-hands-set-deliver-q20-99-raw-read
https://nanoporetech.com/platform/accuracy
https://pmc.ncbi.nlm.nih.gov/articles/PMC11594029
So, if your sequencing data is recent (produced in 2024–25), you may use it for SNP calling. This should be done carefully, of course, as calling some very low frequency variants can still be challenging.
Please accept this part of my comment as a bioinformatics enthusiast.
Regarding the issue with CLC software, my best guess is you were trying to run a workflow/pipeline that contains a tool which is optimized for short Illumina reads, and the ONT reads exceeded its limits, therefore got rejected.
Please be informed there are other CLC tools optimized for long ONT and PacBio reads for steps like importing, read mapping, structural variant calling (variants of length greater than 35bp), and others.
For variant calling of SNPs in particular, if the mapping is produced by the dedicated tools, the existing variant caller can be used. The parameters of the variant callers would need to be adjusted to reflect the coverage profile each sequencing technology brings.
Please accept this part of my comment as a member of the QIAGEN Digital Insights Support team. If you wish to discuss further SNP calling with ONT data using CLC, please write to ts-bioinformatics@qiagen.com. We will be happy to help.
What is the median length of raw reads and how many do you have? Has the data been basecalled with "high" or "super" accuracy?
If you have excessive coverage (> 50x), you could subsample the fastq data and see if CLC is able to work with that.